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Abstract
Interaction between pairs of Staphylococcus aureus replication proteins was detected in an Escherichia coli based two-hybrid
analysis. A reverse two-hybrid system was constructed for selection of compounds that hindered interaction between
interacting protein pairs. A number of cyclic peptides, from a library generated by the split intein-mediated circular ligation
of peptides and proteins technology, were found to interfere with dimerization of the b-sliding clamp of the replisome. Two
8-mer peptides were analyzed in more detail. Both inhibited DNA replication, led to SOS induction, altered cell morphology
and cell death. The peptides were active when added to bacterial cultures indicating that they could traverse the bacterial
membrane to find their intracellular target. Peptide specificity was confirmed by overproduction of the putative target
(DnaN) which resulted in resistance. The minimum inhibitory concentration was ,50 mg/ml for S. aureus cells. These
compounds may serve as lead candidates for future development into novel classes of antibiotics as well as provide
information on the function of the S. aureus replication process.
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Introduction
In recent years, many bacterial pathogens have become
resistant or insensitive to most of the currently available
antibiotics. As a consequence, infections caused by drug-resistant
bacteria, including the Gram-positive methicillin-resistant Staphy-
lococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE)
are associated with increased morbidity, mortality and health-care
costs. The resistance problem has traditionally been addressed by
development of semi-synthetic penicillins and the introduction into
clinical use of novel antibiotic classes. This development peaked in
the 1960’s, and only two new classes of antibiotics, the
oxazolidinones and daptomycin [1,2], have been marketed within
the last 30 years. In order to address the limited treatment options
for several bacterial infections it is important that the development
of antimicrobials continue and include both new targets for
intervention as well as new classes of inhibitors.
Chromosome duplication is an essential process in all living
organisms and the multienzyme machinery that replicates
bacterial DNA represents one such underexploited target. In
bacteria the replication process is carried out by highly conserved
proteins, which deviate from their eukaryotic counterparts in
structure and sequence (reviewed by [3]). Compounds that target
bacterial DNA replication are therefore expected to have a high
therapeutic index. Most of our current knowledge on bacterial
chromosome replication comes from studies of E. coli. The DnaA
replication initiator protein is an AAA+ protein that binds either
ATP or ADP. DnaA associated with either nucleotide binds a
number of high affinity sites in the E. coli replication origin, oriC,
throughout the cell cycle to form the pre-replicative complex [4].
Formation of a DnaA-ATP sub-complex at the binding sites in the
left half of oriC and flanking the DUE (Duplex Unwinding
Element) region is essential for helicase loading, and is stimulated
by the formation of a second DnaA sub-complex in the right half
of oriC [5]. At initiation DnaA-ATP molecules cooperatively bind
the left half of the origin to form a right-handed DnaA-ATP helix,
where individual DnaA molecules interact through their AAA+
domains [5,6], with oriC DNA wrapped around it. Binding of IHF
immediately upstream of the DUE flanking R1 DnaA-box
introduces a 160u bend in the DNA reversing the orientation of
the DNA helical axis and assist in melting the DUE region. One of
the exposed single-stranded DUE regions is fixed by binding the
existing DnaA-ATP helix while the other strand is exposed for
DnaC assisted DnaB helicase loading by the DnaA molecule
bound to the R1 box. Further opening of the duplex allows for
loading of the second helicase by one or more N-terminal domains
of the DnaA-ATP filament [5]. Although promoted by formation
of a DnaA oligomer on oriC, the exact mechanism for helicase
loading at the origin differ between bacteria (for review see [7]).
After helicase loading, a cascade of events leading to replisome
assembly and the beginning of the elongation follows [8]. The
replisome structure was recently covered in an excellent review [3]
and consists of a primosome complex and a PolIII holoenzyme
complex, where each PolIII holoenzyme complex can be further
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divided into three different complexes: PolIII core (aeh), the sliding
clamp (b2) and the clamp loader (t3dd’yx). The core polymerase
needs the sliding clamp for processivity, which in turn is loaded
onto the DNA by the clamp loader.
In the firmicutes including S. aureus, the process of elongation is
similar to that in E. coli with a couple of notable exceptions. The S.
aureus helicase (called DnaC) is loaded by the DnaI helicase loader
assisted by the DnaB and DnaD proteins [9] and two different
replicative polymerases are used. The DnaE which is homologous
to the E. coli PolIIIa only extends RNA primers initially and hands
them off to PolC which is responsible for the processive synthesis
(reviewed in [10]). A third difference was recently revealed. Primer
hand off in Bacillus subtilis, can occur after the synthesis of only two
nucleotides by the DnaG primase [11] and does not require other
replication proteins. This is in contrast to the three-point switch
hand off mechanism in E. coli. Here the x polypeptide of the clamp
loader interacts with SSB to displace DnaG from the SSB-DnaG
complex resulting in release of the primer which is then extended
by the processive polymerase [12].
In all bacteria examined so far the ring shaped b-clamp is a
homodimer which encircles the DNA and slides along the duplex
bringing the polymerase into contact with the DNA to ensure
processivity [13]. The b-clamp interacts with many different
proteins including DnaE, PolC, d, PolIV (DinB), PolV (UmuC/D),
PolI, MutS, MutL, DNA ligase and Hda. These proteins all
contain a conserved b-binding motif (QLS/PLPL or QL
D/SLF)
which binds a hydrophobic pocket located in each DnaN
protomer. The b-sliding clamp has been the target for potential
new antibiotics and two different approaches have been used to
identify compounds that block the peptide-binding pocket of b.
First, synthetic peptides containing the beta-binding domain
QLD/SLF were found to inhibit PolC-b2 and d-b2 interactions
[14] and similarly peptides containing b-binding sequence from d
and Hda bound the b-clamp and inhibited DNA synthesis in vitro
[15]. Subsequently more efficient binders were identified by
modification of the b-binding domain [16,17] and these optimized
peptide motifs have served as starting point for small molecule
mimics to identify compounds that inhibit the a-b2 interaction at
micromolar concentrations [17]. In the second approach, a
fluorescence based peptide displacement assay was used to identify
small compounds that bind to the peptide-binding pocket of b
[18]. One compound, RU7, which inhibited PolII, PolIII and
PolIV although to different extents was identified from a collection
of 30,600 polar organic compounds. It was suggested that RU7
can be used as a starting point for rational drug design to create
stronger inhibitors of replication.
A fairly unexploited class of compounds that has attracted
attention as putative antimicrobials is peptides. The extensively
studied natural antimicrobial peptides are produced by multicel-
lular organisms and the majority act by insertion and alteration/
damage of cytoplasmic membranes via formation of ion channels
or transmembrane pores, but other have been associated with
intracellular targets such as DNA and RNA synthesis and
inhibition of enzymatic activities [19,20]. This indicates that
certain peptides can traverse the bacterial membrane to find their
intracellular targets. This suggests that synthetic peptides may be
tailored for use as inhibitors of intracellular targets, as proven for
synthetic linear peptides targeting holiday junction resolution [21].
A major limitation for the clinical use of antimicrobial peptides is
poor proteolytic stability. This may in part be overcome by
cyclization, which also confers conformation which may also
influence the biological activity of the peptides [22–24].
Here we report the identification of small cyclic peptides with
the ability to prevent dimerization of the b-clamp and hence DNA
replication in S. aureus. Peptide circularization in vivo was achieved
by manipulation of protein splicing (SICLOPPS; split intein-
mediated circular ligation of peptides and proteins) which utilizes
the DnaE split intein of Synechocystic sp. PCC6803 [23,25–28]. This
method coupled to reverse bacterial two-hybrid system allowed us
to select peptides that were able to decrease protein-protein
interactions of selected pairs of replication proteins. Peptides
targeting DnaN-DnaN interaction were further characterized with
respect to target specificity and activity. A similar approach has
earlier been used to identify cyclic peptides that inhibit the E. coli
ribonucleotide reductase by hampering association between NrdA
and NrdB subunits [29].
Results
Protein-protein interactions in the replicative DNA polymerase
and its loaders have been extensively characterized by biochemical
and biophysical approaches. In order to demonstrate in vivo
interactions between S. aureus replication proteins in E. coli we used
the bacterial two hybrid (BTH) system developed by Karimova
et al. [30]. This system is based on interaction-mediated recon-
struction of adenylate cyclase activity in the adenylate cyclase
deficient E. coli strain BTH101 (Table 1). In this system the Cya
protein of Bordatella pertussis is split into two domains (T18 and T25)
resulting in loss of activity. If T18 and T25 are fused to interacting
polypeptides the two Cya domains will be brought into proximity
of each other to create a Cya+ phenotype. This results in cAMP
production and consequently in activation of cAMP-CAP regu-
lated promoters (e.g the lac promoter).
We fused holA, holB, dnaA, dnaB, dnaN, dnaX and polC of S. aureus
to the T18 and T25 fragments of Cya from B. pertussis. Plasmid
pairs were transformed into BTH101 to detect interacting partner
proteins. We observed detectable interaction between the b-clamp
(encoded by dnaN) and the clamp loader (encoded by dnaX, holA
and holB) as well as between the components of the clamp loader
(Table 2). PolC interacted with the b-clamp and DnaX of the
clamp loader. Furthermore, the following interactions were
observed: PolC-PolC, DnaN-DnaN, DnaX-DnaX, DnaB-DnaB
and DnaA-DnaA. The DnaA-DnaA interaction resulted in very
pale blue colonies indicating weak interaction in this assay
(Table 2). Growth of E. coli cells expressing either of these S.
aureus replication proteins was not affected. This suggests that none
of these proteins interfere negatively with their E. coli counterparts.
We failed to construct fusions between DnaC and either Cya
fragment suggesting that these are toxic to their E. coli hosts.
Selection for compounds that disrupt protein-protein
interaction
To directly select for compounds that prevent specific protein-
protein interactions we developed a reverse BTH (R-BTH) system
based on 5-fluoroorotic acid (5-FOA) selection of PyrF2 cells
(Fig. 1A). The non-toxic compound 5-FOA is converted to the
toxic 5-flurouracil by orotidine-59-phosphate decarboxylase, the
product of the E. coli pyrF gene. Bacterial PyrF+ cells are therefore
not able to grow in rich medium containing 5-FOA, whereas
PyrF2cells are.
We moved the pyrF gene from its original position on the
chromosome and placed it in front of lacZ in the BTH101 strain,
resulting in strain SC01. Interaction between the T18 and T25
fusion proteins results in expression of pyrF and consequently
inhibition of growth on 5-FOA containing LB plates (Fig. 1B).
We initially tested the R-BTH system with T18 and T25 vectors
without fusion partners. This did not result in a PyrF+ phenotype
and hence growth was observed in the presence of 5-FOA. On the
Inhibitors of the b-Sliding Clamp of S. aureus
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other hand, the same vectors fused to strong interaction partners
(ZIP motif) resulted in a PyrF+ phenotype and inviability in the
presence of 5-FOA (Table 3).
To determine whether the R-BTH system could be used to
select for compounds that prevent interaction between S. aureus
replication proteins we tested all the interacting protein pairs
previously identified (Table 2). Eight sets of interacting proteins
(DnaN-HolA, DnaN-HolB, DnaN-DnaX, DnaX-HolB, DnaA-
DnaA, PolC-PolC, HolB-HolA and HolB-HolB) did not result in
growth inhibition of the R-BTH strain SC01 in the presence of 5-
FOA (Table 3). On the other hand, five sets of interacting proteins
(PolC-DnaX, PolC-DnaN, DnaN-DnaN, DnaX-DnaX and
DnaB-DnaB) all resulted in a PyrF+ phenotype and hence inability
to grow in the presence of 5-FOA. Thus, we conclude that we can
use our R-BTH system to select for compounds that prevent
interactions between these five pairs of S. aureus replication proteins
when expressed in E. coli.
Intracellular production of cyclic peptides
We used the SICLOPPS technology for intracellular synthesis of
cyclic peptide libraries [23]. Cyclic peptides were chosen over their
linear counterparts to limit degradation by cellular proteases. We
initially tested the SICLOPPS system by inserting the coding
region for amino acids 1286 (Domain I) of DnaA from E.coli
between the C- and N-terminal parts of the split intein.
Induction of the intein-DnaA1-86 fusion resulted initially (after
3 hrs) in production of two protein bands of approximate size
28 kD, which presumably corresponds to the unspliced fusion
protein (Fig. 2A). Two faster migrating protein bands of
approximately 10 kD were also observed, albeit in lower amounts.
These presumably represent the spliced and cyclic DnaA1286
fragment. A longer induction time (20 hrs) resulted in an increased
ratio of circular DnaA1286/precursor (Fig. 2A). We do not know
the reason for both precursor and splice product appearing as
double bands.
Expression of the intein-DnaA1286 fusion resulted in inhibition
of growth and cell filamentation (Fig. 2B). Because all cells
contained a mix of precursor and splice product it was not clear
which species were responsible for filamentation. We therefore
mutated the splice site at the IntC-DnaA1286 (IntC-HNS-
DnaA1286 to IntC-QYS-DnaA1286) junction to prevent splic-
ing. Expression of the presumably splice-deficient precursor did
not majorly affect cell growth or morphology (not shown), and we
can conclude that the growth inhibition observed (Fig. 2B) mainly
result from the cyclic DnaA1286 protein fragment. Although
recent biochemical and structural data indicate that domain III
and IV of DnaA are responsible for forming DnaA oligomers at
oriC [6,31,32], Domain I was also reported to be involved in
oligomerization in addition to its well-recognized role in helicase
loading [7,8,33,34], Expression of Domain I may therefore
Table 1. Bacterial strains.
Strain/plasmid Genotype/plasmid properties Reference
MG1655 Wild-type E. coli [57]
KG22 C600 lacIq lacZDM15 [58]
DH10B F– mcrA D (mrr-hsdRMS-mcrBC) W80lacZDM15 DlacX74 recA1 endA1
araD139 D (ara leu) 7697 galU galK rpsL nupG l–
[59]
BTH101 F2, cya-99, araD139, galE15, galK16, rpsL1 (StrR), hsdR2, mcrA1, mcrB1. [30]
BTH101DpyrF DpyrF This work
SC01 BTH101DpyrF, placZ ::pyrF This work
RN4220 Restriction-defective derivative of S. aureus RN450 [60]
8325-4 S. aureus [61]
MTH157 S. aureus, recA-lacZ transcriptional fusion [62]
doi:10.1371/journal.pone.0072273.t001
Table 2. Protein-protein interactions between the S. aureus replicative proteins determined in the BTH system.
T18/T25 HolA (d) HolB (d`) DnaA DnaB DnaN (b) DnaX (t) PolC Vector Zip
HolA (d) 2
HolB (d`) + +
DnaA 2 2 +
DnaB 2 2 2 ++
DnaN (b) + ++ 2 2 +++
DnaX (t) 2 ++ 2 2 ++ ++
PolC 2 2 2 2 ++ ++ ++
Vector 2 2 2 2 2 2 2 2
Zip 2 2 2 2 2 2 2 2 +++
The relative strength of protein-protein interaction was determined as b-galactosidase level in the BTH assay. (2) white colonies, (+) light blue colonies, (++) blue
colonies and (+++) dark blue colonies.
doi:10.1371/journal.pone.0072273.t002
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interfere with replication initiation either at the level of open
complex formation or helicase loading [33,35].
Identification of cyclic peptides that inhibit DnaN-DnaN
interaction
Having established the SICLOPPS system for intracellular
production of cyclic peptides, we proceeded to construct a peptide
library where the produced 21 amino acids (aa) contain a 6 aa
randomized sequence. Peptides of 6 aa were previously isolated to
inhibit holiday junction resolution [36] and we assumed that this
length would be sufficient for our use as well. The library contains
900,000 combinations, of cyclic peptides with the sequence
SIIDSAGNNNNNNGASTSESG.
The library was screened for peptides able to disrupt DnaN-
DnaN interaction of the Staphylococcus replisome by transforming
into the R-BTH strain SC01 containing interacting Cya fusion
proteins. Cells were plated on plates containing 5-FOA and 1 mM
IPTG to induce expression of the cyclic peptides. We readily
identified clones where expressed peptides restored cell viability in
the presence of 5-FOA (Fig. 3A). To initially assess the activity of
the selected peptides we determined their ability to reduce DnaN-
DnaN interaction in the original two hybrid system. The b-
galactosidase activities measured were reduced to 20240% of the
initial level by all selected peptides, demonstrating that these
efficiently reduced dimerization of the S. aureus DnaN proteins in
E. coli (Fig. 3B). The peptide sequences were determined by
sequencing of the expression plasmids and are shown in Table 4.
Peptide activities
All of the peptides originally identified as inhibitors of DnaN
dimerization came from our 21-mer library (Table 4). Four of
these, III-5, III-6, III-7 and IV-N8 were subsequently reduced to
8-mers with the sequence SXXXXXXG while retaining their
ability to interfere with DnaN dimerization (not shown). Therefore
the activity followed the sequence of the 6 amino acids that were
randomized in the libraries. We proceeded to purify peptides III-5,
III-6 and III-8 using the pTWIN system (New England Biolabs).
Due to the nature of this system, the sequences of purified peptides
were CRXXXXXX. Other peptides such as III-7 and IV-N8
were synthesized chemically (Table 4). The proper purity of and
structure of peptides was determined by gel electrophoresis and
mass spectrometry (not shown).
The antibacterial activities of the purified peptides were
determined against Staphylococcus epidermidis and S. aureus. Cyclic
peptides III-5 and III-6 both had MIC values against S. aureus of
approximately 50 mg/ml whereas they were somewhat more
potent against S. epidermidis (not shown). Cyclic peptide III-7 was
only tested against S. epidermidis and had a MIC value of
approximately 20 mg/ml (Table 4). Peptide III-8 which also was
efficient in reducing DnaN-DnaN interaction when produced
Figure 1. Reverse bacterial two hybrid system. A: In the E. coli two-hybrid interacting proteins X and Y fused to B. pertussis adenylate cyclease
T18 and T25 fragments will restore enzyme activity, resulting in cAMP production, and in association with the catabolite activator protein (CAP)
activation of cAMP dependent promoters In the reverse two-hybrid system, the pyrF gene was placed downstream of the lac promoter, hence
activation by cAMP results in pyrF expression. The pyrF gene encodes orotidine-5 9-phosphate decarboxylase which can convert 5-fluoroorotic acid (5-
FOA) to the toxic compound 5-flourouracil whuich results in inviability. If the interaction between X and Y is abolished by a small compound (filled
red circle) cAMP will no longer be produced and viability restored. B: Fusion of DnaN to both T18 and T25 results in inhibition of growth on 5-FOA
plates due to reconstitution of a functional Cya protein. In the absence of fusion partners T18 and T25 will not form a functional andenylate cyclase.
Therefore pyrF is not expressed and cells remain viable in the presence of 5-FOA.
doi:10.1371/journal.pone.0072273.g001
Inhibitors of the b-Sliding Clamp of S. aureus
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intracellularly failed to inhibit S. aureus growth at 100 mg/ml,
which was the highest concentration tested (Table 4). We can
conclude that some but not all of the identified cyclic peptides are
able to penetrate the bacterial membrane to find their intracellular
target. When we tested the linear counterparts of our isolated
peptides they all had MIC values above 560 mg/ml against S.
epidermidis, indicating little or no activity. As expected none of the
peptides isolated had any activity towards E. coli, whereas they
inhibited growth of B. subtilis, another gram positive bacterium
(data not shown).
Overexpression of DnaN in S. aureus results in resistance
towards peptides III-5 and III-6
To ensure that the antibacterial effects of peptides III-5 and III-
6 were the result of direct interaction of these peptides with the b-
clamp, we decided to overproduce DnaN in S. aureus cells. The
dnaN gene was cloned under control of the cadmium induclible
pCAD promoter of plasmid pCN51 [37]. Cells were grown
exponentially at 37uC in LB medium and 3 hours prior to peptide
addition expression of dnaN was induced by addition of 10 mM
CdCl2. At time T=0 peptides III-5 or III-6 were added to a final
concentration of 40 mg/ml which is very close to the MIC value
for both of these peptides (Fig. 4). Addition of either peptide led to
a cessation of bacterial growth of the uninduced cultures for the
8 hours duration of the experiment. On the other hand cultures
that had been induced with cadmium and hence overproduced
DnaN continued growth in the presence of either peptide (Fig. 4).
We can therefore conclude that overproduction of the putative
target for peptides III-5 and III-6 results in resistance towards the
peptides, and their antibacterial effect is therefore likely to result
from direct interaction with the DnaN protein.
Peptide III-5 and III-6 inhibit DNA replication
In order to test the direct effects of peptides III-5 and III-6 on
DNA replication in S. aureus, strain 8325-4 was grown
exponentially at 37uC in LB medium. Incorporation of 3H-
thymidine into the DNA was determined at various times after
addition of 50 mg/ml of peptides III-5 or III-6. Both peptides
severely reduced accumulation of DNA (Fig. 5). Protein synthesis,




















aStrength of protein-protein interaction was obtained as in Table 2.
bWas determined by plating on LB plates containing 1.3 mg/ml of 5-FOA. –
indicates no growth, whereas + indicates appearance of colonies after 2 days
incubation at 30uC.
Interacting pairs of proteins that did not promote growth on 5-FOA plates can
be used in a selection for inhibitory compounds.
doi:10.1371/journal.pone.0072273.t003
Figure 2. Intracellular production of cyclic DnaA1-86. Expression of IntC::DnaA1286::IntN was induced by addition of 2 mM IPTG to cells
growing exponentially at 30uC or by plating exponential growing cells on plates containing 2 mM IPTG followed by incubation at 30C. A. Intein-DnaA
precursor and splice products were visualized by Western blot using polyclonal anti-DnaA antibodies. B. Growth on LB plates containing 2 mM IPTG
(top) and phase-contrast images (bottom) of expressing IntC::IntN (left) or after three hours expression of IntC::DnaA1286::IntN (right).
doi:10.1371/journal.pone.0072273.g002
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determined as incorporation of 35S-methionine, was unaffected
by peptide addition for at least 180 minutes (Fig. S1) which is
well after the onset of DNA synthesis inhibition. Therefore the
DNA replication inhibition is not a consequence of a more
general effect on protein synthesis, and we conclude that peptide
III-5 and III-6 inhibits replication by interfering with the dnaN
encoded b-clamp.
To test whether the cessation of DNA accumulation was
accompanied by induction of the SOS response we measured the
effects of both peptides on induction of the recA gene. Strain
Figure 3. Identification of peptides that interfere with DnaN-DnaN interaction. In the reverse two-hybrid strain (SC01) interaction between
T18:DnaN and DnaN:T25 resulted in inability to grow in the presence of 5-FOA (A panel; vector). After screening of our SICLOPPS library, growth was
restored in 7 clones.A. (B) The cyclic peptides identified in (A) were expressed in the original bacterial two-hybrid strain (BTH101) containing
T18:DnaN and DnaN:T25 fusion plasmids and the level of b-galactosidase activity was determined as described in Materials and Methods.
doi:10.1371/journal.pone.0072273.g003
Table 4. Peptides identified that target the b-sliding clamp.
Name Sequence1 Purified/synthesized as: MIC for linear peptide mg/ml (mM) MIC for cyclic peptide mg/ml (mM)
II-1 WAGSWG NP ND ND
III-5 VFLCGC CRVFLCGC2 .6834 (0.76) 505 (57)
III-6 SQGLFK CRSQGLFK2 .12284 (1.31) 505 (54)
III-7 GHVWVD CRGHVWVD3 .6734 (0.69) 204 (21)
III-8 STFESL CRSTFESL2 ND .100 (.108)
IV-N4 FADCQE NP ND ND
IV-N8 CWLFVL CRCWLFVL3 .11244 (.1.08) .1004,6 (.98)
1Selected as SIIDSAGXXXXXXGASTSESG.
2Purified using the Impact Twin System (New England Biolabs).
3Synthesized via FMOC SPPS.
4Determined for S. epidermidis.
5Determined for S. aureus.
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MTC157 contains a recA-lacZ transcriptional fusion in its
chromosome. Addition of either peptide to this strain resulted in
a ,50% increase in b-galactosidase activity after 210 minutes
(Fig. 6). The level of induction was less that that observed for the
DNA damaging agent mitomycin C (about 3-fold increase after
210 minutes). It is likely that both peptides results in malfunction-
ing of the replisome, and this provides the signal for SOS
induction in these cells.
The effect of peptides III-5 and III-6 on cell size and DNA
content was visualized by fluorescence microscopy. Five hours
incubation with 50 mg/ml of peptide III-6 resulted in increased
cell size, with some cells obtaining an almost balloon like
appearance (Fig. 7; only data for peptide III-6 is shown). DAPI
staining revealed an uneven DNA distribution between cells
(Fig. 7). A likely explanation is that peptide III-6, through its
inhibitory effect on DNA synthesis, also results in an inability for
cells to divide. Similar observations have been made for E. coli
where failure to complete chromosome replication result in
division inhibition and filamentation [38].
Prolonged exposure to peptides III-5 and III-6 result in
cell death
To investigate whether peptides III-5 and III-6 acted as
bacteriocidal or bacteriostatic agents, we used the BacLightTM
bacterial viability kit (Invitrogen Inc). S. aureus or B. subtilis cultures
were grown exponentially in LB and at an optical density
OD600 = 0.1 peptides were added to a final concentration equal
to the MIC value and incubation continued. In the absence of
peptide, we observed mostly live (green) cells (Fig. 8). On the
other hand, a 6 hour incubation in the presence of peptide III-5 or
III-6 resulted in a mixture of dead (red) and live (green) cells
(Fig. 8). By quantification of the data obtained we calculated that
28% or 49% of the cells were dead after incubation for 6 hours
with peptide III-5 and III-6, respectively. In contrast we only
observed 1% dead cells after incubation with a control buffer for
6 hours. Incubation with the cyclic peptides also resulted in
enlargement of S. aureus cells and filamentation of B. subtilis. Thus,
long term exposure of S. aureus and B. subtilis to either peptide
results in cell death.
Figure 4. Overproduction of DnaN in S. aureus relieves the
growth inhibition imposed by peptides III-5 and III-5. S. aureus
strain 8325-4 containing either the vector plasmid pCN51 (black filled
squares) or plasmid pSC141 (grey triangles) was grown exponentially at
37uC in LB medium supplemented with 10 mg/ml erythromycin. CdCl2
was added to all cultures to a final concentration of 10 mM to induce
overproduction of DnaN from pSC141 three hours prior to peptide
addition. At T = 0, 40 mg/ml of peptide III-5 (middle panel) or III-6
(bottom panel) was added to the cultures. The number of colony
forming units was determined by plating. The experiment were
repeated 4 times with similar results. The figure shows one
representative experiment.
doi:10.1371/journal.pone.0072273.g004
Figure 5. Peptides III-5 and III-6 Inhibit DNA replication. S.
aureus strain 8325-4 was grown exponentially in LB supplemented with
50 mg/ml uridine and 3H-thymidine as described in Materials and
Methods. At T = 0 peptide III-5 (grey triangles) or III-6 (green squares)
was added to a final concentration of 50 mg/ml. Addition of buffer (red
filled circles) served as control. Samples were taken at the indicated
time-points and incorporation of 3H into DNA was measured by liquid
scintillation counting of TCA precipitated material. The experiment
were repeated 3 times with similar results. The figure shows one
representative experiment.
doi:10.1371/journal.pone.0072273.g005
Figure 6. Peptide III-5 and III-6 induces the SOS response in S.
aureus. S. aureus strain MTH157 (recA::lacZ) was grown exponentially in
LB medium at 37uC. At an optical density OD600 = 0.1, Mitomycin C or
Peptides III-5/III-6 were added to final concentrations of 2 mg/ml or
50 mg/ml, respectively. At the times indicated, samples were taken and
the level of b-galactosidase determined (Materials and Methods).
doi:10.1371/journal.pone.0072273.g006
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Discussion
We have used a reverse two hybrid system to identify small
cyclic peptides of 8 amino acids that reduce dimerization of the S.
aureus b-sliding clamp when expressed in E. coli. Some peptides
were able to enter sensitive bacterial cells and cause arrest of
growth and/or cell death due to cessation of bacterial DNA
replication.
The bacterial b-clamp is a homodimer resulting from head to tail
association of two three-domain monomers [39,40] whereas the
eukaryotic counterpart, PCNA, is a homotrimer of two-domain
monomers [41]. Furthermore the sequence identity between sliding
clamps from S. aureus and humans is limited to 10.8% (Fig. 9).
Altogether this suggests that any compound interfering with the
function of the bacterial clamp may not affect the human
counterpart, and it has indeed been the target for inhibition in a
number of earlier studies. Whereas the previous efforts have
focussed on targeting the hydrophobic pocket that interact with
other proteins whose action is needed at the fork [14,17,42] we have
chosen to interfere with dimerization of the clamp. Amajor concern
of ours was that the selection system used was based on a bacterial
two-hybrid system [30] and hence carried out in E. coli. Any broad
spectrum peptide, i.e. targeting both gram positive and gram
negative bacteria, would therefore be counterselected due to death
of the E. coli host. The structure of the S. aureus b-sliding clamp is not
determined, but whenwemodelled it with the SAM-T08 server [43]
the resemblance to the E. coli counterpart was striking (Fig. 9).
However the sequence identity was only 25.7% (Fig. 9) and we
assumed that our approach could be used to isolate peptides that
differentiate between the b-clamp of S. aureus andE. coli. This turned
out to be the case since the peptides isolated were active against the
Gram positive bacteria S. aureus, S. epidermidis and B. subtilis, but did
not affect growth of the Gram negativeE. coli. The sequence identity
between the b-clamp of S. aureus and S. epidermidis and S. aureus and B.
subtilis is 93.4% and 54.1% respectively. The isolated peptides were
not expected to affect the human b-clamp (PCNA) due to the limited
sequence identity to the S. aureus counterpart (Fig. 9). This
assumption remains to be verified experimentally. None of the
identified peptides showed homology to the S. aureus b-clamp. This
does however not rule out the possibility that they interact with the
dimerization interface of DnaN. At present the exact targets on the
DnaN protein are not known.
The idea of using peptides as antimicrobial agents is not new.
Naturally occurring antimicrobial peptides and their derivatives
have for a long time been considered for therapeutic use [44].
Both synthetic linear and cyclic peptides that target intracellular
processes have been isolated and extensively characterized [21,29].
Our approach of using a reverse bacterial two-hybrid system to
identify cyclic peptides, generated by the SICLOPPS technology,
that interfere with protein-protein interaction was originally
developed by Benkovic and co-workers to identify peptides
interfering with the function of the ribonucleotide reductase
(RNR). RNR is a tetramer consisting of two NrdA and two NrdB
subunits and peptides were selected based on their ability to
prevent NrdA and NrdB interaction [29]. This is to our knowledge
the first attempt to isolate cyclic peptides that target the DNA
replication machinery directly. Two lines of evidence suggest that
we have been successful in this. First, two peptides with the
sequences VFLCGC and SQGLFK (III-5 and III-6; Table 4)
Figure 7. Peptide III-6 affect S. aureus cell size, morphology and
DNA content. S. aureus strain 832524 was grown exponentially at
37uC in LB medium. Peptide III-6 was added at 50 m/m1 (MIC value) and
incubation continued for 4 hours. Cells were stained with DAPI prior to
fluorescence microscopy (Materials and Methods).
doi:10.1371/journal.pone.0072273.g007
Figure 8. Peptides III-5 and III-6 lead to cell death in S. aureus and B. subtilis. S. aureus strain 8325-4 and B. subtilis strain 168 were grown
exponentially in LB medium at 37uC. Peptides III-5 and III-6 were added at their MIC values (50 mg/m1) and incubation continued for 6 hours. Cells
were live/dead stained with the BacLight system (Materials and Methods) prior to fluorescence microscopy.
doi:10.1371/journal.pone.0072273.g008
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inhibited DNA synthesis without affecting protein synthesis when
added to a culture of S. aureus. Second, overproduction of the
DnaN target resulted in resistance towards the same peptides. We
therefore consider it unlikely that the antimicrobial effect of these
two peptides result from other and unspecific interactions with the
bacterial cells.
Peptides III-5, III-6 and III-7 had a somewhat limited activity in
vivo with MIC values in the range of 20250 mg/ml. Since the
peptides were all efficient in reducing DnaN-DnaN interaction
when produced intracellularly (Fig. 3) the MIC values may at least
in part reflect difficulties for the peptides in crossing the bacterial
membrane. In agreement with this none of these peptides were
particularly hydrophobic or cationic (Table 4). At present we do
not know how the isolated peptides enter the bacterial cell but
given their physical/chemical nature, they are not likely to
passively diffuse through the membrane, and a possibility is that
they are actively taken up by one of the four oligopeptide
permeases present in S. aureus cells [45]. This could be tested by
construction of deletion mutants lacking one or more of these
permeases. We synthesized and tested linear counterparts of the
active peptides III-5, III-6 and III-7. None of these linear peptides
had any antimicrobial activity (MIC.560 mg/ml) against either S.
aureus or S. epidermidis (not shown; Table 4). This may indicate a
decreased proteolytic stability of the linear peptides once inside
cells, or may simply reflect a different three-dimentional structure
that does not target the b-clamp to the same extent as when
circularized. Increased antibacterial activity of peptides due to
circularization has previously been described [46].
Addition of peptides III-5 and III-6 to growing and replicating
cells resulted in increased expression from the promoter of the
SOS regulated recA gene. At the replication fork, the b-clamp
associated with leading strand synthesis is loaded at initiation of
replication and remains associated with the PolIII core enzyme
throughout the replication period. However, the appearance of
lesions in the DNA may result in replication restart which requires
re-loading of the b-clamp [47]. The situation is different for the
lagging strand where a new b-clamp is loaded for the synthesis of
each Okazaki fragment [48]. Interfering with DnaN dimerization
may therefore interfere with both leading and lagging strand
synthesis. We suggest that this would initially lead to accumulation
of single stranded DNA within the cells which would trigger SOS
induction (Fig. 6) and later lead to generation of double stranded
breaks. Similarly, chronic SOS induction has been observed in the
temperature sensitive dnaN159 mutant of E. coli which is impaired
Figure 9. Sequence and structural similarities between b clamps from E. coli, S. aureus and human. Left: Alignment of S. aureus DnaN, E.
coli DnaN and human PCNA protein sequences using vector NTI deluxe v. 9.0 (Informax Inc.). Yellow: Identical residues in all three species. Blue:
Identical residues in two of the three species. Amino acids that are similar in two of the three species are in green. Right: Structure prediction of the
same proteins made by the SAM-T08 server (http://compbio.soe.ucsc.edu/papers/sam_doc/sam_doc.html).
doi:10.1371/journal.pone.0072273.g009
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in interaction with PolIII [49]. One of the hallmarks of SOS
induction in bacteria is an arrest in cell division resulting from
increased expression of the sfiA/sulA gene [38]. In rod shaped
bacteria such as E. coli the net result is cell filamentation and this is
also what we observed for rod-shaped B. subtilis cells after
prolonged exposure to DnaN targeting peptides (Fig. 8). For
coccoid S. aureus and S. epidermidis cells we observed that treatment
with the same peptides led to enlarged spherical cells and we
suggest that this also may result from peptide-mediated arrest in
cell division (Fig. 4). We also observed that peptide treated cells
varied greatly in DNA content as judged from microscopic studies.
These observations are in agreement with uncoupling of leading
and lagging strand synthesis which result in failure to complete
chromosome replication which may, by segregation failure,
explain the appearance of DNA less cells as well as cells containing
an increased amount of DNA. A further contribution to the latter
could be the occurrence of damage induced DNA replication [50]
triggered by strand breaks.
Strand breaks as a result of DnaN inhibition may be sufficient to
explain why peptides III-5 and III-6 are bacteriocidal upon
prolonged exposure. This situation may be parallel to that elicited
by gyrase inhibitors such as ciprofloxacin which trap the gyrase
molecule at the DNA cleavage stage and eventually result in
formation of double stranded breaks [51].
Clearly the potency of our first generation of peptides targeting
the b-clamp of Gram positive bacteria is too poor for direct testing
as new antimicrobials. However they may still serve as lead
compounds on the way to identify more efficient versions, for
example by Quantitative Structure-Activity Relationship (QSAR)
modeling, to relate structural characteristics of the peptides to
biological activity [52,53]. A key question is whether their limited
activity results from poor entry into bacterial cells, poor interaction
with their target or both. It is also our hope that these peptides
along with others that target other key interactions between
replication proteins will turn out as useful tools for studying DNA
replication in vivo.
Materials and Methods
Bacterial strains, plasmids, primers and growth
conditions
All bacterial strains are listed in Table 1. Details on plasmid
construction and primer sequences can be found in Table S1 and
S2. Cells were grown in LB or TB medium at the temperature
indicated. Antibiotics were used at the following concentrations:
Ampicillin (100 mg/ml for high copy number plasmids and 50 mg/
ml for mini R1 plasmids), Chloramphenicol (20 mg/ml), Kana-
mycin (50 mg/ml), Erythromycin (10 mg/ml).
E. coli strain BTH101DpyrF was constructed as follows: First,
pyrF was replaced with the cat gene on the chromosome of
MG1655 by the procedure described by Datsenko and Wanner
[54] using the primers Delta pyrF up and Delta pyrF down and
pKD3 as template. Primer sequences are given in Table S3.
Second, the DpyrF::cat allele was P1 transduced into BTH101.
Finally, the chloramphenicol resistance gene were removed as
described [54] resulting in BTH101npyrF.
For construction of E. coli strain SC01 (BTH101npyrF,
pyrF::lacZ), pyrF was amplified by PCR from MG1655 with
primers parAsd pyrF up and pyrF hindIII down. The sequences of
primers are given in Table S3. The PCR product was digested
with BamHI and HindIII and inserted into BamHI-HindIII
treated pTK532 resulting in pSC533. Plasmid pSC533 contains
pyrF inserted downstream of the cat gene from pKD3 flanked by
two FRT sites. Primers lacZ-cI up and pSC532 lacZ down contains
sequences homologous to sites downstream of the lacZ promoter
on the E. coli chromosome. These primers were used to generate
PCR fragments containing pyrF linked to the cat gene and the two
FRT sites using pSC533 as template. The PCR product was
digested with DpnI and transformed by electroporation into
MG1655 and the cells were spread on LB plates containing
20 mg/ml chloramphenicol. The resulting pyrF::lacZ fusion was
transduced into BTH101DpyrF. The chloramphenicol resistance
gene were removed as described [54] resulting in BTH101npyrF,
pyrF::lacZ.
Bacterial two-hybrid assay
Bacterial two-hybrid assay was performed as described previ-
ously [30]. Derivatives of plasmids pUT18 and p25N encoding
replication proteins were constructed by cloning PCR-amplified
DNA fragments in frame with the T25 and T18 fragments of cya.
T18 and T25 fusions were transformed into BTH101, and plated
on plates containing 40 mg/ml of 5-bromo-4-chloro-indolyl-b-D-
galactoside (X-gal) and relevant antibiotics. Interacting protein
fusions resulted in development of blue colonies on the X-gal
plates. For b-galactosidase assays, cells were grown exponentially
at 30uC in LB supplemented with 0.5 mM IPTG, and b-
galactosidase activities were measured as described by [55].
Western blot analysis
Strain KG22/pSC116 was grown exponentially at 30uC in LB
supplemented with 50 mg/ml chloramphenicol. Expression of
IntC::DnaA1-86::IntN was induced by addition of 2 mM IPTG.
Samples were taken at selected times and fractionated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (Criterion-Pre-
cast Gel; 10 to 20%Tris-HCl; Bio-Rad Inc.). After fractionation the
proteins were transferred to a polyvinylidene difluoride membrane,
0.2 mm (Millipore), using a semidry blotting apparatus (Bio-Rad
Inc.). The membrane was blocked overnight in TBSa (150 mM
NaCl, 50 mM Tris-HCl, pH 10) plus 2% Tween 20, rinsed with
TBSa plus 0.05% Tween for 5 min, incubated for 2 h with
polyclonal rabbit anti-DnaA antiserum, and washed with TBSa
plus 0.05% Tween. The membrane was further incubated for 1.5 h
in the presence of porcine anti-rabbit immunoglobulin G antibody
conjugated to alkaline phosphatase (DAKO A/S) and washed with
TBSa plus 0.05% Tween. The membrane was scanned on a Storm
840 imaging system (Molecular Dynamics Inc.).
Construction of SICLOPPS libraries
Construction of a 21 amino acid library was done by annealing
100 pmol of each of the three primers Library ClaI-1, Library
ClaI-2 and EGFP primer 3 in a 50 ml reaction by heating to 80uC
followed by cooling to room temperature over a period of
60 minutes. The sequences of primers are given in Table S3. The
annealed oligonucleotides were ligated to 20 mg of pSC118
digested with ClaI and SpeI. The ligation reaction was ethanol
precipitated and the library was resuspended in 100 ml TE buffer
and transformed into electrocompetent DH10B. This library
encodes precursors of cyclic peptides of 21 amino acids of which 6
are randomized. The library contains approximately 900.000
cyclic peptides which are expressed upon addition of IPTG.
Screening of SICLOPPS library
The 21aa library was transformed into SC01 containing cya18
and cya25 fusion plasmids. The amount of 5-FOA was titrated so
strains with plasmids encoding interacting partners did not
produce any colonies while strains only expressing the Cya18
and Cya25 partners grew. The cyclic peptides were expressed in
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vivo by addition of IPTG to the plates. Plasmid was purified from
colonies that grew on 5-FOA plates and re-transformed into SC01
containing the relevant fusion partners.
Purification of cyclic peptides
Cyclic peptides were purified using the Impact Twin System
(New England Biolabs). Overnight cultures of BL21/pSC124G-C
and BL21/pSC143 was diluted in TB medium supplemented with
500 mg/ml ampicillin and grown at 30uC. Plasmids pSC124G-C
and pSC143 are derivatives of pTWIN1 with the sequence of the
cyclic peptide to be purified inserted between the DnaB and Mxe
inteins. At an optical density of OD600 = 0.821.0, IPTG was
added to a final concentration of 1 mM. The temperature was
decreased to 25uC and induction was carried out for 4 hours. The
cyclic peptides were purified as recommended by New England
Biolabs with the following exception. The on column cleavage of
the Mxe GyrA intein was performed in 25 mM Tris-Hcl, pH
8.5+100 mM NaCl +50 mM MESNA. The cyclic peptide was
eluted in 25 mM Tris-Hcl, pH 8.5+100 mM NaCl.
Synthesis of 8-mers by Fmoc-Solid Phase Peptide
Synthesis (SPPS)
2-chlorotrityl chloride Resin-linked amino acids were purchased
from Bachem. Fmoc-protected amino acids, NMP, DTT, TFA
and DIC were supplied by Iris Biotech. Acetonitrile, acetic acid
and DCM were from VWR; HOAt were purchased from GL
Biochem Shanghai; DMF was from Milligen; and DIEA, TFE and
TIS were supplied by Sigma Aldrich Inc.
The peptides were synthesized manually using 10 ml syringes
containing PTFE syringe filters. Differently from nature, the
peptides were synthesized from the C- to the N-terminus. The 2-
chlorotrityl chloride resin-linked amino acids used for the different
peptides and their resin loadings were: H-Cys (Trt) -2-ClTrt-Resin
for peptide III-5 (0.57 mmol/g loading); H-Lys(Boc)-2-CLTrt-
Resin for peptide III-6 (0.46 mmol/g loading); H-Leu-2-ClTrt-
Resin for peptide IV-N8 (0.98 mmol/g loading); H-Asp (OtBu) -
2ClTrt-Resin for peptide III-7 (0.83 mmol/g loading). Swelling of
resin took place overnight in N-methylmorpholine (NMP), prior to
synthesis and NMP was vacuum removed. Fmoc-protected amino
acids (4 equivalents) were diluted in 0.4 M 1-hydroxy-7-azabenzo-
triazole (HOAt) in NMP. Fmoc-deprotection was done by 20%
piperidine in N-methyl-2-pyrrolidone (NMP) for 3 min, followed
by NMP wash (3 times) and another deprotection with 20%
piperidine in DMF for 7 min. 1,3-diisopropylcarbodiimide (DIC)
(4 equivalents) was added to the Fmoc-protected amino acid in
HOAt/NMP solution before each coupling. Coupling and
decoupling took place for 2 hours and between these steps wash
was performed using NMP. Fmoc-deprotection was done after
each recoupling step as described above, followed by NMP wash
(10 min).
Linear peptides were obtained by treating the synthesized
peptides with 1 ml of TFA:TIS:DTT:H2O (88:2:5:5), accompa-
nied by wash with 4 ml of 95% TFA [56]. They were
concentrated under nitrogen evaporation, followed by ether wash
(4 ml twice) and lyophilization. The samples were analyzed by
analytical RP-HPLC (C12 column, 1.5 ml/min flow and linear
gradient of A= 0.1% TFA in MilliQ water and B= 0.1%TFA in
acetonitrile) and MALDI TOF-MS.
Prior to cyclization, the synthesized peptides were washed twice
with ethanol. Resin was removed with 2 ml of AcOH/TFE/
DCM (1:2:7) for 2 hours accompanied by wash with the same
cocktail mixture (4 ml twice). The crude protected linear peptides
were concentrated as described above. They were dissolved in
minimal amount of DMF. HBTU (3 equivalents) and DIEA (6
equivalents) in DMF was added stepwise to the dissolved peptides
at a time interval of 30 minutes. Cyclization took place overnight
and DMF was removed via nitrogen evaporation. Removal of side
protecting groups was achieved by treatment with 1 ml TFA:-
TIS:DTT:H2O (88:2:5:5), accompanied by wash with 4 ml of
95% TFA. The crude cyclic peptides were concentrated and
precipitated via nitrogen evaporation and ether washing respec-
tively. Preparative RP-HPLC provided with a Vydac C18 column
was used to purify the crude cyclic peptides, with eluting linear
gradient of A= 0.1% TFA in MilliQ water and B= 0.1%TFA in
acetonitrile over 85 minutes (flow of 4 ml/min). Fractions were
collected and analyzed by analytical RP-HPLC and MALDI
TOF-MS.
The matrix used for verification of masses of linear and cyclic
peptides via MALDI TOF-MS was a-cyano-p-hydroxycinammic
acid, made in water/acetonitrile (7:3) with 0.1%TFA.
Measurement of DNA synthesis
For measuring DNA and protein synthesis, S. aureus strain
832524 was grown exponentially at 37uC in LB supplemented
with 0.2 ml 3H-thymidine (20 Ci/mmol,1 mCi/ml; Perkin Elmer
Inc.) and uridine (50 mg/ml). Peptides were added at the MIC at
time zero, and samples of 0.5 ml were taken at the indicated
timepoints. The cells were lyzed by addition of 1 ml lysostaphin
(5 mg/ml) followed by incubation at 37uC for 30 minutes. TCA
was added to a final concentration of 10% and the mixtures were
incubated on ice for 30 minutes. The TCA insoluble material was
transferred to scintillation tubes. The incorporation of 3H into
DNA was determined using a 1450 MicroBeta TriLux Microplate
and Scintillation and Luminiscence counter (Perkin Elmer Inc.).
Microscopy
S. aureus strain 8325-4 or B. subtilis strain 168 was grown
exponentially at 37uC in LB. Peptides were added to the MIC at
time zero and samples were taken for DAPI staining after 4 hours
and after 6 hours for the live dead stain (BacLight live/dead staining
kit from invitrogen). The cells were stained with the live/dead stain
according to the manufacturer. Phase-contrast and fluorescence
images were acquired using a Leica DM5000B microscope with
a6100 HCX PL APO NA 1.4 objective and a Leica DFC350FX
cooled charge-coupled device camera controlled through FW4000
software (version 1.2.1; Leica Microsystems).
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